Legorreta Pablo G. is CEO, Chairman of the Board of Royalty Pharma plc. Currently has a direct ownership of 882,495 shares of RPRX, which is worth approximately $29.4 Million. The most recent transaction as insider was on May 16, 2025, when has been sold 530,348 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 882K
1283.33% 3M change
1283.33% 12M change
Total Value Held $29.4 Million

Legorreta Pablo G. Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2025
BUY
Other acquisition or disposition
-
530,348 Added 37.54%
882,495 Class A Ordinary Shares
May 08 2025
BUY
Grant, award, or other acquisition
-
288,352 Added 45.02%
352,147 Class A Ordinary Shares
Nov 16 2023
SELL
Other acquisition or disposition
-
383,000 Reduced 85.72%
63,795 Class A Ordinary Shares
Apr 14 2022
SELL
Other acquisition or disposition
-
350,000 Reduced 84.58%
63,795 Class A Ordinary Shares

Also insider at

EPZM
Epizyme, Inc. Healthcare
DNAC
Social Capital Suvretta Holdings Corp. III
LPG

Legorreta Pablo G.

CEO, Chairman of the Board
Winston Salem, NC

Track Institutional and Insider Activities on RPRX

Follow Royalty Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPRX shares.

Notify only if

Insider Trading

Get notified when an Royalty Pharma PLC insider buys or sells RPRX shares.

Notify only if

News

Receive news related to Royalty Pharma plc

Track Activities on RPRX